Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
We use cutting-edge technology and treatment options to ensure the best possible outcomes for our patients
Summary: GLP-1 receptor agonists are not specifically licensed for menopausal weight gain but may be prescribed for women meeting obesity treatment criteria (BMI 35 kg/m with comorbidities) during the menopausal transition
In 2-year rat carcinogenicity studies referenced in the Increlex label, increased mammary and skin tumor incidence occurred at high IGF-1 exposure
If youre wondering whether hydration or nutrient IV therapy might benefit you, its important to consider your symptoms, recent health events, and overall medical history
Ongoing Study Visits: Throughout the trial, participants return for regular visits
